title: Development of daptomycin for gram-positive infections.
authors.affiliation: Cubist Pharmaceuticals, Inc., 24 Emily Street, Cambridge, MA 02139, USA. ftally@cubist.com
authors.forename: F P
authors.initials: FP
authors.lastname: Tally
authors.forename: M F
authors.initials: MF
authors.lastname: DeBruin
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D017576:Daptomycin / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin